Center for Vaccine Research

A man in a light blue shirt leaning against a reflective surface
Pitt’s Jonas Salk Chair for Vaccine Research explains why we need multiple candidate vaccines, what’s special about SARS-CoV-2 and why he’s hopeful about the future.
A man in a white shirt
When Jonas Salk and his Pitt team, supported by March of Dimes, tackled the polio pandemic, they came up with creative ways to make and distribute the vaccine. Dr. Rahul Gupta of March of Dimes explains why that sort of approach is needed to eradicate COVID-19 today.
Angus in a blue suit
Published as part of a four-article package today in JAMA, research led by Pitt’s Derek Angus found that an inexpensive treatment of steroids can substantially improve survival in critically ill COVID-19 patients. The findings, part of a multi-site global trial, were so stark that the World Health Organization is updating its treatment guidance for the disease.
Roc wearing a blue Pitt t-shirt
Proceeds from a new Pitt Athletics T-shirt are supporting the Center for Vaccine Research in its work developing a COVID-19 vaccine to emerge “Over Fate and Foe Victorious.”
A person in a yellow t-shirt and face mask walks on campus
Expert faculty members in the University of Pittsburgh’s School of Medicine are at the helm of a new COVID-19 Medical Response Office, which will oversee the implementation of a virus monitoring program on all five Pitt campuses. The program will direct the University’s COVID-19 testing, contact tracing, reporting procedures and isolation and quarantine protocols.
Haberman in a headset and yellow sweater
Through good times and bad, the University’s phones never stop ringing—ever wonder who answers? For two decades, it’s been Senior Switchboard Operator Lin Haberman and a small team. Learn how the calls have changed over the years and get a behind-the-scenes look at how COVID-19 is different from any other event the switchboard’s seen.
A backlit woman looks into a scope with a computer monitor behind her displays a glowing green image
Federal funding is an important part of supporting research and innovation in universities. Pitt’s Evan Facher describes how the novel coronavirus could change the equation.
Paul Duprex in a suit and green tie
The Coalition for Epidemic Preparedness Innovations is committing nearly $5 million to a consortium that includes the University of Pittsburgh’s Center for Vaccine Research to develop a vaccine for the novel coronavirus.
Naeem Aziz, wearing a black coat and shirt, speaking to panelist Zhaojin Zeng, wearing a light blue dress shirt in front of a crowd
More than 250 people attended a panel discussion on Feb. 12 to hear a group of Pitt and county experts discuss the coronavirus outbreak.
Duprex in a suit and green tie in front of a University of Pittsburgh background
The University of Pittsburgh is among a select few institutions expected to receive samples of the coronavirus for study. In his remarks to the University Senate, Paul Duprex, director of the Center for Vaccine Research, highlighted the tremendous history the University has in working on vaccines and why this matters.